Related Experiment Video
Updated: Oct 3, 2026

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
A novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor
Jin Na Shin1, Injune Kim, Jung Sup Lee
1National Research Laboratory for Bone Metabolism and School of Dentistry, Chosun University, Gwangju 501-759, Korea.
Abstract:
A variety of surface receptors eliciting diverse cellular responses have been shown to recruit tumor necrosis factor receptor-associated factor (TRAF) adaptor molecules. However, a few TRAF-interacting intracellular proteins that serve as downstream targets or regulators of TRAF function have been identified. In search of new intracellular molecules that bind TRAF6, we carried out a yeast two-hybrid cDNA library screening with an N-terminal segment of TRAF6 as the bait. A novel human C(2)H(2)-type zinc finger family protein was identified, which when coexpressed with TRAF6 led to a suppression of TRAF6-induced activation of NF-kappa B and c-Jun N-terminal kinase. This novel protein was designated TIZ (for TRAF6-inhibitory zinc finger protein). TIZ expression also inhibited the signaling of RANK (receptor activator of NF-kappa B), which together with TRAF6 has been shown to be essential for osteoclastogenesis. Furthermore, the expression level of TIZ appeared to be regulated during the differentiation of human peripheral blood monocytes into osteoclasts. More significantly, transfection of TIZ into the monocyte/macrophage cell line Raw264.7 reduced the RANK ligand-induced osteoclastogenesis of this cell line. Our findings suggest that the novel zinc finger protein TIZ may play a role during osteoclast differentiation by modulating TRAF6 signaling activity.
Insights
Researchers discovered TIZ, a novel zinc finger protein that inhibits TRAF6 signaling. TIZ plays a role in osteoclast differentiation by modulating this pathway, impacting bone cell formation.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- Tumor necrosis factor receptor-associated factors (TRAFs) are key adaptor molecules in cellular signaling pathways.
- Identifying TRAF-interacting proteins is crucial for understanding downstream cellular responses.
- Limited intracellular proteins regulating TRAF function have been identified.
Purpose of the Study:
- To identify novel intracellular proteins that interact with TRAF6.
- To investigate the functional role of a newly identified TRAF6-binding protein in cellular signaling and osteoclastogenesis.
Main Methods:
- Yeast two-hybrid cDNA library screening using a TRAF6 N-terminal segment as bait.
- Coexpression assays to assess the effect of the novel protein on TRAF6-induced signaling.
- Analysis of RANK signaling and osteoclast differentiation in cell lines.
Main Results:
- A novel human C(2)H(2)-type zinc finger protein, designated TIZ (TRAF6-inhibitory zinc finger protein), was identified.
- TIZ suppressed TRAF6-induced activation of NF-kappa B and c-Jun N-terminal kinase.
- TIZ inhibited RANK signaling and reduced RANK ligand-induced osteoclastogenesis in Raw264.7 cells, with its expression regulated during monocyte differentiation into osteoclasts.
Conclusions:
- The novel zinc finger protein TIZ modulates TRAF6 signaling activity.
- TIZ plays a significant role in regulating osteoclast differentiation.
- TIZ represents a potential therapeutic target for conditions involving osteoclast activity.
Related Concept Videos
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Canonical Wnt Signaling Pathway
Osteoclasts in Bone Remodeling